StockWatch
·

Eris Lifesciences Ltd Q4 FY25 Results

ERISQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue705.303.0%
Total Income713.252.5%
Expenditure584.445.0%
PBT128.8110.9%
Net Profit102.3517.7%
OPM35.78%39.41pp
NPM14.35%2.47pp
EPS6.9012.2%
View full financials

Informational and educational content only. Not investment advice.